• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲印度裔和华裔患者脂蛋白(a)水平的种族和民族差异

Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients.

作者信息

Banerjee Dipanjan, Wong Eric C, Shin Jessica, Fortmann Stephen P, Palaniappan Latha

机构信息

Program on Prevention Outcomes and Practices, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

J Lipids. 2011;2011:291954. doi: 10.1155/2011/291954. Epub 2011 May 23.

DOI:10.1155/2011/291954
PMID:21660301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3108091/
Abstract

Background. Lipoprotein (a) [Lp(a)] is an independent risk factor for cardiovascular disease (CVD) in Non-Hispanic Whites (NHW). There are known racial/ethnic differences in Lp(a) levels, and the association of Lp(a) with CVD outcomes has not been examined in Asian Americans in the USA. Objective. We hypothesized that Lp(a) levels would differ in Asian Indians and Chinese Americans when compared to NHW and that the relationship between Lp(a) and CVD outcomes would be different in these Asian racial/ethnic subgroups when compared to NHW. Methods. We studied the outpatient electronic health records of 2022 NHW, 295 Asian Indians, and 151 Chinese adults age ≥18 y in Northern California in whom Lp(a) levels were assessed during routine clinical care from 2001 to 2008, excluding those who had received prescriptions for niacin (14.6%). Nonparametric methods were used to compare median Lp(a) levels. Significance was assessed at the P < .0001 level to account for multiple comparisons. CVD outcomes were defined as ischemic heart disease (IHD) (265 events), stroke (122), or peripheral vascular disease (PVD) (87). We used logistic regression to determine the relationship between Lp(a) and CVD outcomes. Results. Both Asian Indians (36 nmol/L) and NHW (29 nmol/L) had higher median Lp(a) levels than Chinese (22 nmol/L, P ≤ .0001 and P = .0032). When stratified by sex, the differences in median Lp(a) between these groups persisted in the 1761 men (AI v CH: P = .001, NHW v CH: P = .0018) but were not statistically significant in the 1130 women (AI v CH: P = .0402, NHW v CH: P = .0761). Asian Indians (OR = 2.0) and Chinese (OR = 4.8) exhibited a trend towards greater risk of IHD with high Lp(a) levels than NHW (OR = 1.4), but no relationship was statistically significant. Conclusion. Asian Indian and NHW men have higher Lp(a) values than Chinese men, with a trend toward, similar associations in women. High Lp(a) may be more strongly associated with IHD in Asian Indians and Chinese, although we did not have a sufficient number of outcomes to confirm this. Further studies should strive to elucidate the relationship between Lp(a) levels, CVD, and race/ethnicity among Asian subgroups in the USA.

摘要

背景。脂蛋白(a)[Lp(a)]是非西班牙裔白人(NHW)心血管疾病(CVD)的独立危险因素。已知Lp(a)水平存在种族/民族差异,在美国亚裔美国人中尚未研究Lp(a)与CVD结局的关联。目的。我们假设,与NHW相比,亚洲印度人和华裔美国人的Lp(a)水平会有所不同,并且与NHW相比,这些亚洲种族/民族亚组中Lp(a)与CVD结局之间的关系也会有所不同。方法。我们研究了北加利福尼亚州2022名NHW、295名亚洲印度人和151名年龄≥18岁的华裔成年人的门诊电子健康记录,这些人在2001年至2008年的常规临床护理期间接受了Lp(a)水平评估,排除了那些接受过烟酸处方的人(14.6%)。采用非参数方法比较Lp(a)水平中位数。为了考虑多重比较,在P <.0001水平评估显著性。CVD结局定义为缺血性心脏病(IHD)(265例事件)、中风(122例)或外周血管疾病(PVD)(87例)。我们使用逻辑回归来确定Lp(a)与CVD结局之间的关系。结果。亚洲印度人(36 nmol/L)和NHW(29 nmol/L)的Lp(a)水平中位数均高于华裔(22 nmol/L,P≤.0001和P =.0032)。按性别分层时,这些组之间Lp(a)中位数的差异在1761名男性中持续存在(亚洲印度人与华裔:P =.001,NHW与华裔:P =.0018),但在1130名女性中无统计学意义(亚洲印度人与华裔:P =.0402,NHW与华裔:P =.0761)。亚洲印度人(OR = 2.0)和华裔(OR = 4.8)与NHW(OR = 1.4)相比,Lp(a)水平高时患IHD的风险有增加趋势,但无统计学意义。结论。亚洲印度男性和NHW男性的Lp(a)值高于华裔男性,女性中也有类似关联趋势。高Lp(a)可能与亚洲印度人和华裔的IHD关联更强,尽管我们没有足够数量的结局来证实这一点。进一步的研究应努力阐明美国亚洲亚组中Lp(a)水平、CVD与种族/民族之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdc/3108091/13a5d38d4335/JL2011-291954.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdc/3108091/13a5d38d4335/JL2011-291954.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abdc/3108091/13a5d38d4335/JL2011-291954.001.jpg

相似文献

1
Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients.亚洲印度裔和华裔患者脂蛋白(a)水平的种族和民族差异
J Lipids. 2011;2011:291954. doi: 10.1155/2011/291954. Epub 2011 May 23.
2
Temporal Trends in Cardiovascular Disease Prevalence Among Asian American Subgroups.亚裔美国人亚群中心血管疾病患病率的时间趋势。
J Am Heart Assoc. 2024 Apr 16;13(8):e031444. doi: 10.1161/JAHA.123.031444. Epub 2024 Apr 12.
3
Spectrum of cardiovascular diseases inAsian-American racial/ethnic subgroups.亚裔美国人种族/民族亚群中的心血管疾病谱。
Ann Epidemiol. 2011 Aug;21(8):608-14. doi: 10.1016/j.annepidem.2011.04.004.
4
Disparities in COVID-19 testing and outcomes among Asian American and Pacific Islanders: an observational study in a large health care system.美国亚裔和太平洋岛民群体在新冠病毒检测和结果方面的差异:在一个大型医疗保健系统中的观察性研究。
BMC Public Health. 2023 Feb 6;23(1):251. doi: 10.1186/s12889-023-15089-w.
5
Heterogeneity in the Prevalence of Cardiovascular Risk Factors by Ethnicity and Birthplace Among Asian Subgroups: Evidence From the 2010 to 2018 National Health Interview Survey.亚洲亚群中按族裔和出生地划分的心血管危险因素流行率的异质性:来自 2010 至 2018 年全国健康访谈调查的证据。
J Am Heart Assoc. 2024 Mar 5;13(5):e031886. doi: 10.1161/JAHA.123.031886. Epub 2024 Feb 29.
6
Racial/Ethnic Differences in Gestational Diabetes Prevalence and Contribution of Common Risk Factors.妊娠期糖尿病患病率的种族/民族差异及常见危险因素的作用
Paediatr Perinat Epidemiol. 2015 Sep;29(5):436-43. doi: 10.1111/ppe.12209. Epub 2015 Jul 22.
7
Prevalence of low vitamin D levels among older US Asian and Pacific Islander adults.美国老年亚裔和太平洋岛民维生素 D 水平低的流行率。
Osteoporos Int. 2024 Nov;35(11):2017-2024. doi: 10.1007/s00198-024-07197-z. Epub 2024 Aug 29.
8
Lipoprotein(a) Levels in Disaggregated Racial and Ethnic Subgroups Across Atherosclerotic Cardiovascular Disease Risk Levels.不同动脉粥样硬化性心血管疾病风险水平下不同种族和族裔亚组的脂蛋白(a)水平。
JACC Adv. 2024 May 2;3(6):100940. doi: 10.1016/j.jacadv.2024.100940. eCollection 2024 Jun.
9
Prevalence of cardiovascular disease among Asian, Pacific Islander and multi-race populations in Hawai'i and California.夏威夷和加利福尼亚州亚裔、太平洋岛民和多种族人群中心血管疾病的患病率。
BMC Public Health. 2023 May 15;23(1):885. doi: 10.1186/s12889-023-15795-5.
10
Overweight and Obesity Differences Across Ethnically Diverse Subgroups of Asian American Men.亚裔美国男性不同族裔亚人群的超重和肥胖差异。
Am J Mens Health. 2018 Nov;12(6):1958-1965. doi: 10.1177/1557988318793259. Epub 2018 Aug 10.

引用本文的文献

1
Factors Associated with Lipoprotein(a) Testing Among Multiethnic Individuals.多民族个体中与脂蛋白(a)检测相关的因素。
J Gen Intern Med. 2025 Mar;40(4):756-763. doi: 10.1007/s11606-024-09126-6. Epub 2024 Oct 25.
2
Association between lipoprotein(a) plasma levels and diabetic nephropathy in Han Chinese patients with type 2 diabetes mellitus.脂蛋白(a)血浆水平与汉族 2 型糖尿病患者糖尿病肾病的关系。
PLoS One. 2024 May 14;19(5):e0299240. doi: 10.1371/journal.pone.0299240. eCollection 2024.
3
Consideration and Application of Lipoprotein(a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults.

本文引用的文献

1
Lipoprotein(a) as a cardiovascular risk factor: current status.脂蛋白(a)作为心血管风险因素:现状。
Eur Heart J. 2010 Dec;31(23):2844-53. doi: 10.1093/eurheartj/ehq386. Epub 2010 Oct 21.
2
Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians.南亚人、中国人和欧洲白种人中脂蛋白A(LPA)基因座的基因组变异及其与血浆脂蛋白(a)关系的综合分析。
Circ Cardiovasc Genet. 2010 Feb;3(1):39-46. doi: 10.1161/CIRCGENETICS.109.907642. Epub 2009 Dec 30.
3
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
成人动脉粥样硬化性心血管疾病风险评估中脂蛋白(a)的考量与应用
CJC Open. 2023 Nov 18;6(3):597-606. doi: 10.1016/j.cjco.2023.11.015. eCollection 2024 Mar.
4
Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity.按种族和民族划分的、用于动脉粥样硬化性心血管疾病的指南指导他汀类药物使用模式及差距。
Am J Prev Cardiol. 2024 Mar 11;17:100647. doi: 10.1016/j.ajpc.2024.100647. eCollection 2024 Mar.
5
Cardiovascular Risk Management in the South Asian Patient: A Review.南亚患者的心血管风险管理:综述
Health Sci Rev (Oxf). 2022 Sep;4. doi: 10.1016/j.hsr.2022.100045. Epub 2022 Aug 3.
6
Assessment of Associations Between Serum Lipoprotein (a) Levels and Atherosclerotic Vascular Diseases in Hungarian Patients With Familial Hypercholesterolemia Using Data Mining and Machine Learning.利用数据挖掘和机器学习评估匈牙利家族性高胆固醇血症患者血清脂蛋白(a)水平与动脉粥样硬化性血管疾病之间的关联
Front Genet. 2022 Feb 9;13:849197. doi: 10.3389/fgene.2022.849197. eCollection 2022.
7
High lipoprotein(a) concentrations are associated with lower type 2 diabetes risk in the Chinese Han population: a large retrospective cohort study.高脂蛋白(a)浓度与中国汉族人群 2 型糖尿病风险降低相关:一项大型回顾性队列研究。
Lipids Health Dis. 2021 Jul 27;20(1):76. doi: 10.1186/s12944-021-01504-x.
8
Lipids in South Asians: Epidemiology and Management.南亚人的脂质情况:流行病学与管理
Curr Cardiovasc Risk Rep. 2019 Aug;13(8). doi: 10.1007/s12170-019-0618-9. Epub 2019 Jul 11.
9
Recent Updates of Lipoprotein(a) and Cardiovascular Disease.脂蛋白(a)与心血管疾病的最新进展
Chonnam Med J. 2021 Jan;57(1):36-43. doi: 10.4068/cmj.2021.57.1.36. Epub 2021 Jan 25.
10
Lipoprotein (a) and the risk of elevated depressive symptoms: The Multi-Ethnic Study of Atherosclerosis.脂蛋白(a)与抑郁症状加重风险:动脉粥样硬化多族裔研究
J Psychiatr Res. 2021 Jan;133:119-124. doi: 10.1016/j.jpsychires.2020.12.022. Epub 2020 Dec 13.
脂蛋白(a)浓度与冠心病、中风及非血管性死亡风险
JAMA. 2009 Jul 22;302(4):412-23. doi: 10.1001/jama.2009.1063.
4
Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.基因水平升高的脂蛋白(a)与心肌梗死风险增加
JAMA. 2009 Jun 10;301(22):2331-9. doi: 10.1001/jama.2009.801.
5
Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians.年轻亚洲印度人脂蛋白(a)水平、载脂蛋白(a)异构体与早发冠心病家族史之间的关联
Clin Biochem. 2008 May;41(7-8):453-8. doi: 10.1016/j.clinbiochem.2008.01.016. Epub 2008 Feb 5.
6
Lipoprotein(a) and cardiovascular disease in ethnic Chinese: the Chin-Shan Community Cardiovascular Cohort Study.华裔人群中的脂蛋白(a)与心血管疾病:金山社区心血管队列研究
Clin Chem. 2008 Feb;54(2):285-91. doi: 10.1373/clinchem.2007.090969. Epub 2007 Dec 18.
7
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.普通人群中极高脂蛋白(a)水平与心肌梗死风险:哥本哈根城市心脏研究
Circulation. 2008 Jan 15;117(2):176-84. doi: 10.1161/CIRCULATIONAHA.107.715698. Epub 2007 Dec 17.
8
First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B.首个用于免疫测定的世界卫生组织/国际临床化学和检验医学联合会脂蛋白(a)国际参考试剂——Lp(a) 标准物质2B。
Clin Chem Lab Med. 2004;42(6):670-6. doi: 10.1515/CCLM.2004.114.
9
Cardiovascular disease in non-Western countries.非西方国家的心血管疾病。
N Engl J Med. 2004 Jun 10;350(24):2438-40. doi: 10.1056/NEJMp048024.
10
Lp(a) lipoprotein, vascular disease, and mortality in the elderly.脂蛋白(a)、血管疾病与老年人死亡率
N Engl J Med. 2003 Nov 27;349(22):2108-15. doi: 10.1056/NEJMoa001066.